MedPath

Histamed

Brand Name: Histamed

Generic Name: Cetirizine Hydrochloride

Active
Registration Number

DRP-8610

Dosage Form

Oral Solution

Issuance Date

April 1, 2022

Expiry Date

April 23, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1mg/mL
PackagingAmber Bottle x 30mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
H1-Receptor antagonist (antihistamines)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cetirizine HydrochlorideActive
Monograph: Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform